
Long Covid is a debilitating condition that affects millions of individuals worldwide following an initial COVID-19 infection. Symptoms can persist for months or even years, significantly impacting the quality of life. Patients commonly report fatigue, brain fog, shortness of breath, cardiovascular issues, and clotting abnormalities. Traditional treatments often focus on symptom management rather than addressing the underlying causes.
A promising new approach—Apheresis for Long Covid—is gaining traction as a potential breakthrough treatment. This innovative therapy is designed to remove harmful substances from the blood, restoring normal circulation and reducing inflammation.
Apheresis is a medical procedure that involves the selective removal of specific blood components. The process is widely used in conditions such as autoimmune diseases and lipid disorders. In the context of Apheresis Long Covid, the treatment focuses on removing inflammatory markers, microclots, and other harmful elements that may be contributing to persistent symptoms.
Recent studies have shown that Long Covid Apheresis can effectively remove microclots—tiny fibrin deposits that impair circulation and oxygen delivery. These microclots have been identified as a possible driver of persistent fatigue, shortness of breath, and brain fog in Long Covid patients. By eliminating them, apheresis helps restore normal vascular function and improves overall health.
Inflammation is a major factor in Long Covid symptoms. Apheresis works by removing pro-inflammatory cytokines and immune complexes, which contribute to systemic inflammation. Patients undergoing this treatment often report reduced joint pain, improved mental clarity, and increased energy levels.
In Long Covid cases, autoantibodies, viral remnants, and metabolic waste may accumulate in the bloodstream, triggering ongoing immune responses. Apheresis treatment for Long Covid helps clear these elements, giving the body a chance to reset and heal.
This treatment is particularly beneficial for patients who experience: